Protara Therapeutics (TARA) Institutional Ownership $5.39 +0.21 (+4.05%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Protara Therapeutics (NASDAQ:TARA)CurrentInstitutional OwnershipPercentage38.13%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$2.31MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$56.20K Get TARA Insider Trade Alerts Want to know when executives and insiders are buying or selling Protara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TARA Institutional Buying and Selling by Quarter Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Protara Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC170,040$311K0.0%+21.0%0.824% 11/15/2024 XTX Topco Ltd32,682$60K0.0%N/A0.158% 11/15/2024 Ikarian Capital LLC155,712$285K0.0%-13.8%0.755% 11/6/2024 Oppenheimer & Co. Inc.179,125$328K0.0%+40.8%0.868% 8/15/2024CVI Holdings LLC302,746$630K0.6%N/A1.468% 8/15/2024 Armistice Capital LLC520,000$1.08M0.0%N/A2.521% Get the Latest News and Ratings for TARA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/14/2024 Marshall Wace LLP77,351$161K0.0%N/A0.375% 8/9/2024 Renaissance Technologies LLC150,400$313K0.0%+77.8%0.730% 8/2/2024 Privium Fund Management UK Ltd114,708$233K0.1%-4.2%0.557% 5/17/2024 Ikarian Capital LLC202,701$813K0.1%+7.4%0.984% 5/7/2024 Oppenheimer & Co. Inc.10,000$40K0.0%N/A0.087% 11/6/2023 Assenagon Asset Management S.A.15,831$26K0.0%-45.5%0.140% 7/26/2023 Privium Fund Management B.V.119,730$272K0.1%N/A1.059% 7/25/2023 Assenagon Asset Management S.A.29,051$69K0.0%+67.6%0.257% 2/10/2023 Opaleye Management Inc.2,692,594$7.22M2.5%-0.6%23.892% 2/9/2023 Privium Fund Management UK Ltd119,730$321K0.2%+242.1%1.062% 1/12/2023 Assenagon Asset Management S.A.17,336$46K0.0%-70.3%0.154% 11/14/2022 Boothbay Fund Management LLC18,864$56K0.0%-26.5%0.167% 11/1/2022 Privium Fund Management UK Ltd35,000$104K0.1%N/A0.311% 8/15/2022 Opaleye Management Inc.2,684,167$8.89M4.0%+0.4%23.823% 8/12/2022 Ikarian Capital LLC257,853$756K0.1%-13.0%2.292% 8/12/2022 DLD Asset Management LP157,349$461K0.0%-31.4%1.396% 7/27/2022 Assenagon Asset Management S.A.58,389$171K0.0%+33.5%0.519% 4/25/2022 Assenagon Asset Management S.A.43,741$224K0.0%N/A0.389% 2/22/2022 DLD Asset Management LP229,231$1.55M0.1%N/A2.040% 2/15/2022 Sender Co & Partners Inc.28,502$192K0.1%N/A0.254% 2/15/2022 DLD Asset Management LP229,231$1.55M0.1%N/A2.040% 2/14/2022 Opaleye Management Inc.2,650,000$18.00M3.8%+3.6%23.585% 2/10/2022 Acadian Asset Management LLC17,219$115K0.0%N/A0.153% 11/16/2021 Two Sigma Advisers LP168,818$1.17M0.0%+189.5%1.502% 11/16/2021 Two Sigma Investments LP130,935$906K0.0%+136.3%1.165% 11/15/2021 Marshall Wace LLP15,190$105K0.0%-13.0%0.135% 11/12/2021 Trexquant Investment LP12,454$86K0.0%N/A0.111% 11/12/2021 Renaissance Technologies LLC115,900$802K0.0%+125.4%1.032% 11/12/2021 Jump Financial LLC14,500$100K0.0%N/A0.129% 11/10/2021 Goldman Sachs Group Inc.155,973$1.08M0.0%+17.9%1.388% 11/9/2021BlackRock Inc.44,036$306K0.0%+9.7%0.392% 8/25/2021 Marshall Wace LLP17,469$170K0.0%-58.5%0.155% 8/18/2021 Ikarian Capital LLC584,804$5.70M0.5%-10.0%5.205% 8/17/2021 Millennium Management LLC129,380$1.26M0.0%+115.2%1.151% This Indicator called BOTH NVDA rallies (Ad)Rarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is… Click this link here. 8/16/2021 State Street Corp10,359$101K0.0%-82.8%0.092% 8/16/2021 Goldman Sachs Group Inc.132,257$1.29M0.0%N/A1.177% 8/16/2021 Marshall Wace LLP17,469$170K0.0%-58.5%0.155% 8/13/2021 Renaissance Technologies LLC51,427$501K0.0%+63.8%0.458% 8/13/2021 Northern Trust Corp22,279$217K0.0%-60.7%0.198% 8/13/2021Knott David M36,164$352K0.1%+151.7%0.322% 8/13/2021 Geode Capital Management LLC82,985$808K0.0%-25.3%0.739% 8/13/2021 Vanguard Group Inc.437,108$4.26M0.0%-4.3%3.890% 8/12/2021Ergoteles LLC17,700$172K0.0%N/A0.158% 8/11/2021 Bank of New York Mellon Corp17,907$174K0.0%-30.3%0.159% 8/11/2021 Susquehanna International Group LLP20,609$201K0.0%N/A0.184% 6/10/2021 Perceptive Advisors LLC421,642$6.64M0.1%-30.7%3.755% 5/18/2021 Millennium Management LLC60,134$947K0.0%+8.8%0.536% 5/18/2021 Alyeska Investment Group L.P.109,405$1.72M0.0%+47.0%0.974% 5/18/2021 Citadel Advisors LLC241,514$3.80M0.0%N/A2.151% 5/17/2021 Schonfeld Strategic Advisors LLC23,455$371K0.0%N/A0.209% 5/17/2021 Perceptive Advisors LLC421,642$6.64M0.1%-30.7%3.755% 5/17/2021 Rock Springs Capital Management LP689,942$10.86M0.2%+7.3%6.144% 5/17/2021 Price T Rowe Associates Inc. MD319,326$5.03M0.0%-26.4%2.844% 5/17/2021 Nuveen Asset Management LLC13,940$219K0.0%-43.4%0.124% 5/13/2021 Renaissance Technologies LLC31,400$494K0.0%+83.5%0.280% 5/13/2021 Bank of Montreal Can61,742$954K0.0%+9,988.6%0.550% 5/12/2021 Northern Trust Corp56,676$892K0.0%-10.3%0.505% 5/12/2021 Geode Capital Management LLC111,062$1.75M0.0%+5.9%0.989% 5/12/2021 Panagora Asset Management Inc.5,921$93K0.0%N/A0.053% 5/11/2021 Artisan Partners Limited Partnership379,946$5.98M0.0%+0.9%3.384% 5/7/2021BlackRock Inc.189,876$2.99M0.0%+4.4%1.691% 2/24/2021 Alyeska Investment Group L.P.74,405$1.80M0.0%-62.8%0.664% 2/16/2021 Tri Locum Partners LP39,225$950K0.3%N/A0.350% 2/16/2021 Alyeska Investment Group L.P.74,405$1.80M0.0%-62.8%0.664% 2/16/2021 Nuveen Asset Management LLC24,647$597K0.0%N/A0.220% 2/16/2021 Price T Rowe Associates Inc. MD433,598$10.50M0.0%-3.2%3.867% 2/16/2021 Charles Schwab Investment Management Inc.12,060$292K0.0%N/A0.108% 2/13/2021 American International Group Inc.2,249$54K0.0%+86.5%0.020% 2/12/2021 Ikarian Capital LLC649,542$15.73M0.7%-10.1%5.793% 2/11/2021 Northern Trust Corp63,212$1.53M0.0%+71.3%0.564% 2/10/2021 Renaissance Technologies LLC17,110$414K0.0%-54.7%0.153% 2/10/2021 Artisan Partners Limited Partnership376,733$9.12M0.0%+27.1%3.360% 2/9/2021 Wells Fargo & Company MN13,110$317K0.0%-20.8%0.117% 2/9/2021 Bank of New York Mellon Corp25,142$608K0.0%N/A0.224% 2/5/2021BlackRock Inc.181,888$4.40M0.0%+97.2%1.622% 12/30/2020 Deerfield Management Company L.P. Series C782,670$13.17M0.3%+80.9%6.981% 11/10/2020 State Street Corp23,018$387K0.0%+26.8%0.393% 11/5/2020 Wells Fargo & Company MN16,563$279K0.0%+89.0%0.283% (Data available from 1/1/2016 forward) TARA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TARA shares? During the previous two years, 12 institutional investors and hedge funds held shares of Protara Therapeutics. The most heavily invested institutionals were Opaleye Management Inc. ($7.22M), Armistice Capital LLC ($1.08M), CVI Holdings LLC ($630K), Oppenheimer & Co. Inc. ($328K), Renaissance Technologies LLC ($313K), Geode Capital Management LLC ($311K), and Ikarian Capital LLC ($285K).Learn more on TARA's institutional investors. What percentage of Protara Therapeutics stock is owned by institutional investors? 38.13% of Protara Therapeutics stock is owned by institutional investors. Learn more on TARA's institutional investor holdings. Which institutional investors have been buying Protara Therapeutics stock? Of the 11 institutional investors that purchased Protara Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($520K), CVI Holdings LLC ($302.75K), Privium Fund Management B.V. ($119.73K), Privium Fund Management UK Ltd ($84.73K), Marshall Wace LLP ($77.35K), Renaissance Technologies LLC ($65.80K), and Oppenheimer & Co. Inc. ($61.94K). How much institutional buying is happening at Protara Therapeutics? Institutional investors have bought a total of 1,320,249 shares in the last 24 months. This purchase volume represents approximately $2.86M in transactions. Which Protara Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Protara Therapeutics stock in the last 24 months: Assenagon Asset Management S.A. ($54.27K), Ikarian Capital LLC ($25K), Opaleye Management Inc. ($15.47K), and Privium Fund Management UK Ltd ($5.02K). How much institutional selling is happening at Protara Therapeutics? Institutional investors have sold a total of 99,768 shares in the last 24 months. This volume of shares sold represents approximately $229.76K in transactions. Related Companies ARCT Major Shareholders ZVRA Major Shareholders KOD Major Shareholders CRVS Major Shareholders VERV Major Shareholders YMAB Major Shareholders SIGA Major Shareholders KRRO Major Shareholders AURA Major Shareholders KALV Major Shareholders This page (NASDAQ:TARA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TARA Stock Alerts